Option chain shows key data for AstraZeneca's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AstraZeneca.

AstraZeneca (OTC:AZNCF) Stock, Option Chain

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

AZNCF

RIVN

TSLA

Investors like to think of themselves as rational and unattached. Still, the movement of stock prices shows that this isn’t always true — and the existence of technical signals like oversold or undersold

5 Oversold Stocks to Buy Right Now

Biotech

News

Health Care

Movers

General

Earlier today, AstraZeneca plc (NASDAQ: AZN) 

AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization

Earnings

Large Cap

Guidance

AstraZeneca Plc&#39;s (NASDAQ: AZN) unit Alexion has 

Comments

AstraZeneca

AstraZeneca (AZNCF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga